Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer remains a major global health challenge with limited treatment options.
• Ferroptosis, a form of regulated cell death driven by iron-catalyzed lipid peroxidation, presents a novel therapeutic avenue.
• Bionanotechnology offers innovative tools to target cancer mechanisms.

Purpose of the Study:

• To provide a comprehensive overview of iron-induced cell death and its role in cancer.
• To analyze the potential of nano-drug delivery systems for ferroptosis-based cancer therapy.
• To discuss strategies and challenges for iron-induced nanoagents in cancer treatment.

Main Methods:

• Summarizing the mechanism of iron-induced cell death and its link to cancer.
• Analyzing nano-drug delivery systems for inducing ferroptosis.
• Reviewing strategies like promoting Fenton reactions and inhibiting key ferroptosis regulators (GPX4, glutathione, System Xc⁻).

Main Results:

• Iron-induced cell death, modulated by nanotechnology, shows promise for cancer treatment.
• Various nanodrug delivery strategies can effectively induce ferroptosis.
• Combined therapeutic approaches integrating ferroptosis and nanomedicine are being explored.

Conclusions:

• Iron-induced cell death combined with bionanotechnology represents a promising frontier in cancer therapy.
• Further research into nano-agents targeting ferroptosis is crucial for clinical application.
• Overcoming challenges in application prospects is key for developing effective iron-induced nanoagents.